Technical Analysis for GKOS - Glaukos Corporation

Grade Last Price % Change Price Change
D 98.23 -1.04% -1.03
GKOS closed down 1.04 percent on Friday, April 12, 2024, on 68 percent of normal volume.
Earnings due: May 1
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Overbought Stochastic Strength 0.00%
Down 3 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Stochastic Sell Signal Bearish -1.04%
Multiple of Ten Bearish Other -1.04%
Overbought Stochastic Strength -1.04%
Slingshot Bullish Bullish Swing Setup -1.48%
NR7 Range Contraction -1.48%
NR7-2 Range Contraction -1.48%
Upper Bollinger Band Walk Strength -1.48%

   Recent Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Glaukos Corporation Description

Glaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company is engaged in the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring one millimeter long and 0.33 millimeter wide. MIGS procedures involve the insertion of a micro-scale device from within the eye's anterior chamber through a small corneal incision. Glaukos is also engaged in developing a portfolio of micro-scale injectable therapies, including three pipeline products, namely, the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is an implant that is designed to provide a sustained release of a prostaglandin drug to lower intraocular pressure in glaucoma patients.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Eye Surgery Medical Technology Ophthalmology Ophthalmic Drainage Glaucoma Vision Implant Blindness Incision Eye Surgery Treatment Of Glaucoma Cornea Intraocular Pressure

Is GKOS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 102.33
52 Week Low 45.38
Average Volume 521,024
200-Day Moving Average 78.15
50-Day Moving Average 91.59
20-Day Moving Average 92.69
10-Day Moving Average 96.69
Average True Range 3.34
RSI (14) 61.98
ADX 22.49
+DI 27.02
-DI 16.00
Chandelier Exit (Long, 3 ATRs) 92.32
Chandelier Exit (Short, 3 ATRs) 94.09
Upper Bollinger Bands 102.95
Lower Bollinger Band 82.43
Percent B (%b) 0.77
BandWidth 22.14
MACD Line 2.84
MACD Signal Line 2.01
MACD Histogram 0.831
Fundamentals Value
Market Cap 4.79 Billion
Num Shares 48.8 Million
EPS -2.69
Price-to-Earnings (P/E) Ratio -36.52
Price-to-Sales 15.43
Price-to-Book 9.83
PEG Ratio 1.64
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 101.59
Resistance 3 (R3) 101.58 100.46 101.03
Resistance 2 (R2) 100.46 99.60 100.46 100.84
Resistance 1 (R1) 99.34 99.07 98.78 99.35 100.66
Pivot Point 98.22 98.22 97.94 98.22 98.22
Support 1 (S1) 97.10 97.36 96.54 97.11 95.80
Support 2 (S2) 95.98 96.83 95.98 95.62
Support 3 (S3) 94.86 95.98 95.43
Support 4 (S4) 94.87